ERBB2 and cancer: There was not a significant association between breast cancer subtype and DMR methylation status, with hypomethylation present in 27% of HER2+ cancer, 39% of ER+ cancer, and 63% of TNBC (p = 0.11), with borderline significant association in TNBC, p = 0.06.